Serotonin

Serotonin
CYL · Public domain · source
Name	Serotonin
Pin	3-(2-Aminoethyl)-1H-indol-5-ol
Other names	5-hydroxytryptamine
Formula	C10H12N2O
Molar mass	176.22 g·mol−1

Serotonin is a monoamine neurotransmitter derived from the amino acid tryptophan, involved in diverse physiological and behavioral processes across animals. It participates in vascular tone, gastrointestinal motility, mood regulation, and platelet aggregation, with perturbations implicated in multiple medical conditions. Research on its roles spans basic chemistry, neurobiology, clinical psychiatry, and pharmacology.

Chemistry and Biosynthesis

Serotonin is synthesized from dietary Tryptophan via oxidative decarboxylation through enzymatic action of Tryptophan hydroxylase and Aromatic L-amino acid decarboxylase, a pathway studied in models including Mus musculus, Drosophila melanogaster, and Caenorhabditis elegans; metabolic fate includes conversion to 5-hydroxyindoleacetic acid by Monoamine oxidase and Aldehyde dehydrogenase as characterized in work by researchers affiliated with institutions like National Institutes of Health, Max Planck Society, and Karolinska Institutet. The molecule's indole ring and amine side chain confer reactivity measured by analytical techniques developed at Scripps Research and ETH Zurich. Biosynthetic regulation involves cofactors such as Tetrahydrobiopterin and feedback mechanisms examined in studies funded by agencies including the Wellcome Trust and the European Research Council.

Physiological Functions

Serotonin modulates cardiovascular responses observed in investigations led by groups at Harvard Medical School and Johns Hopkins University, influences enteric nervous system dynamics studied at Massachusetts General Hospital and University College London, and contributes to platelet aggregation processes described in clinical work at Mayo Clinic and Cleveland Clinic. In the central nervous system, serotonergic projections originating in nuclei such as the Raphe nuclei affect sleep–wake cycles researched by teams at Stanford University and University of California, San Francisco, feeding behavior probed in experiments at Columbia University and University of Cambridge, and social behaviors reported in comparative studies at Princeton University and University of Oxford. Peripheral serotonergic signaling also engages pulmonary and hepatic physiology studied at Imperial College London and Johns Hopkins Hospital.

Neurobiology and Receptor Pharmacology

Serotonergic neurons in the Dorsal raphe nucleus and Median raphe nucleus innervate cortical and subcortical targets investigated with techniques from laboratories at Howard Hughes Medical Institute and Cold Spring Harbor Laboratory. Serotonin acts at a family of G protein–coupled receptors and ligand-gated ion channels, including 5-HT1, 5-HT2, 5-HT3, 5-HT4 subtypes characterized in pharmacology texts from Oxford University Press and Cambridge University Press; receptor mapping has been advanced by work at National Institute of Mental Health and Roche. Signaling cascades involving cAMP and Phospholipase C are implicated in synaptic plasticity studies by teams at Yale University and University of Pennsylvania. Developmental roles of serotonergic signaling were detailed in research programs at Massachusetts Institute of Technology and University of Chicago exploring interactions with growth factors described by investigators from Ludwig Maximilian University of Munich.

Clinical Significance and Disorders

Altered serotonergic function is implicated in psychiatric conditions such as major depressive disorder evaluated in clinical trials at Maudsley Hospital and Zucker Hillside Hospital, anxiety disorders treated in centers including Sheppard Pratt Health System and Bellevue Hospital, and obsessive-compulsive disorder studied at NIMH. Peripheral serotonin abnormalities contribute to migraine pathophysiology researched at Johns Hopkins Migraine Program, irritable bowel syndrome investigated at Mayo Clinic Center for Individualized Medicine, and carcinoid syndrome diagnosed in oncology services at Memorial Sloan Kettering Cancer Center. Genetic studies linking transporter polymorphisms to disease phenotypes have been conducted by consortia including the Psychiatric Genomics Consortium and laboratories at Broad Institute.

Pharmacology and Therapeutic Uses

Pharmacotherapies targeting serotonergic systems include selective serotonin reuptake inhibitors developed and evaluated in multicenter trials by pharmaceutical companies and academic centers such as Mount Sinai Health System, Vanderbilt University Medical Center, and Karolinska University Hospital; serotonin receptor agonists and antagonists like triptans for migraine were pioneered in collaborations involving Eli Lilly and Company and GlaxoSmithKline. Drugs affecting serotonin synthesis or breakdown, including monoamine oxidase inhibitors and tryptophan hydroxylase inhibitors, have been developed with regulatory oversight by agencies such as the Food and Drug Administration and the European Medicines Agency. Novel neuromodulation approaches that influence serotonergic tone are investigated in clinical studies at Cleveland Clinic Foundation and Hospital for Special Surgery.

Measurement and Research Methods

Quantification of serotonin and metabolites employs high-performance liquid chromatography techniques standardized at laboratories like NIH Clinical Center and University of Wisconsin–Madison, immunohistochemistry protocols refined at Johns Hopkins University School of Medicine, and in vivo imaging using PET ligands developed by teams at University of Pennsylvania Perelman School of Medicine and Karolinska Institutet. Electrophysiological recordings from serotonergic neurons are conducted in neuroscience centers including Salk Institute and Max Delbrück Center for Molecular Medicine; genetic and optogenetic manipulations use tools originating from groups at Cold Spring Harbor Laboratory and Stanford Neurosciences Institute. Large-scale datasets integrating genomics and neuroimaging have been produced by consortia such as the Human Connectome Project and the ENIGMA Consortium.

Category:Neurotransmitters